#BCAM Trivia Tuesday: According to the National Foundation for Cancer Research (NFCR), more than 1.5 million people in the U.S. are either living with or in remission today from #bloodcancers. At Allogene, we are motivated daily by the strength and resilience of patients living with blood cancer and strive to bring new innovative treatment options to patients. #CART #immunotherapy #celltherapy Learn About AlloCAR T Products: https://lnkd.in/gXiYrYPp
Allogene Therapeutics
Biotechnology
South San Francisco, California 66,285 followers
About us
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.
- Website
-
www.allogene.com
External link for Allogene Therapeutics
- Industry
- Biotechnology
- Company size
- 201-500 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2017
- Specialties
- oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune
Locations
-
Primary
210 E Grand Ave
South San Francisco, California 94080, US
-
7400 Gateway Blvd
Newark, California 94560, US
Employees at Allogene Therapeutics
Updates
-
#BCAM Trivia Tuesday: How many people do you think are living with or in remission today from #bloodcancer in the U.S? Submit your guess below and watch for the answer. 1. 750,000 2. 1.5 million 3. 1.9 million
-
Approximately 30% of #LBCL patients will experience a relapse following 1L treatment. What if there was a way to intervene before relapse becomes a reality? This Blood Cancer Awareness Month we are excited to share more about how we are pioneering a new approach to LBCL treatment with our groundbreaking ALPHA3 trial. Learn more about our commitment to changing the game in LBCL in this post by our CEO, Dr. David Chang. #CART #celltherapy #immunotherapy Blood Cancer Awareness Month: How Novel Trial Design May Revolutionize LBCL Treatment: https://lnkd.in/ghN-S_uG
-
Allogene Therapeutics reposted this
🎥 David Chang, M.D., Ph.D., President & CEO of Allogene Therapeutics, shares his perspective on how lymphoma treatment has transformed over the past 20 years. Hear his expert analysis on the progress and future directions in treatment. Learn more at: https://lnkd.in/eKZYsRn4 #WLAD2024 #HonestTalk #lymsm
-
Since 2018, Allogene has been dedicated to expanding patient access by developing off-the-shelf, on-demand #CART products, with the potential to change the future of cancer care. This #WorldLymphomaAwarenessDay we encourage others to learn more about #bloodcancer. #celltherapy #immunotherapy Learn About AlloCAR T Products: https://lnkd.in/gXiYrYPp
-
Watch our latest DataBrief where Dr. Zachary Roberts, Head of R&D and Chief Medical Officer, talks about the potential of our investigational AlloCAR T™ product cema-cel to become the first #CART treatment available as part of first line therapy. #celltherapy #immunotherapy Watch DataBrief: https://lnkd.in/gyfMGiNJ
-
#BCAM Trivia Thursday: According to the American Cancer Society, there will be an estimated 80,620 new cases of #non-Hodgkin lymphoma in 2024. At Allogene, we are on a mission to bring "off-the-shelf" #CART products to patients in need. #bloodcancer Learn About AlloCAR T Products: https://lnkd.in/gXiYrYPp
-
#BCAM Trivia Tuesday: According to @LLSusa, 157 people die every day from blood cancer. Allogene is committed to expanding access to our investigational AlloCAR T™ products to patients with blood cancer in both community and academic centers. #CART #immunotherapy #celltherapy Learn About AlloCAR T Products: https://lnkd.in/gXiYrYPp
-
#BCAM Trivia Tuesday: Do you know approximately how many people die every day from #bloodcancer? Submit your guess below and watch for the answer. 1. 214 2. 157 3. 87